It was hailed as a breakthrough that would slash levels of this deadly disease, but 17 years later there is a ’troubling spike,‘ despite 80% being ’protected.' Regardless, here’s the medical gaslighting technique they’re using to fool the public.
Story at-a-Glance
- More than 200 strains of human papillomavirus (HPV) have been identified, and about 40 of them can cause cancer, including cervical, penile, oral, vaginal, vulvar and anal cancer. Of these, cervical cancer is the most common type of HPV-related cancer in the U.S.
- The first HPV vaccine, Gardasil, was licensed in 2006. The vaccine was hailed as a breakthrough that would slash cervical cancer rates, but in the real world, it has largely failed to deliver. The original vaccine contained four HPV strains. The latest version contains nine
- Since 2006, cancers associated with the four HPV strains included in the original quadrivalent vaccine have declined by 88% among 14- to 19-year-olds and 81% among women aged 20 to 24
- However, when looking at cervical cancer in general, there’s now a “troubling spike” in rates. Between 2001 and 2018, cervical cancer rates have increased by 1.3% per year. The primary cause for this continued rise appears to be because cancers associated with non-vaccine strains are going up
- Evidence suggests HPV vaccination makes women more susceptible than their nonvaccinated peers to HPV genotypes not covered by the vaccine. So, essentially, women who got the vaccine have traded one risk for another
Ninety percent of HPV infections resolve on their own without treatment, as a well-functioning immune system will keep the virus in check. In rare cases, however, infection with a high-risk HPV that remains untreated and unchecked may turn into cancer.
